Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

SB 1360Session 2025

What changed between versions

1723 paragraphs changed+4890 words added−5307 removed

Highlighted text was added in the newer version. Struck-through text was removed.

Florida Senate

-

2025

CS for SB 1360

By

Senator Leek

the Committee on Criminal Justice; and Senator Leek

7-00152A-25 20251360__591-02560-25 20251360c1

1 A bill to be entitled

2 An act relating to controlled substances; amending s.

3 893.03, F.S.; excepting from the Schedule I controlled

4 substance xylazine drug products approved by the

5 United States Food and Drug Administration labeledfor forcertain

6 use; amending s. 893.13, F.S.; providing criminal

7 penalties and requiring a mandatory minimum term of

8 imprisonment if a person sells, manufactures, or

9 delivers or possesses with intent to sell,

610 and prescribedmanufacture, or dispenseddeliver by veterinariansxylazine; addingamending s. 893.135,

11 F.S.; creating the offense of trafficking in xylazine;

12 providing criminal penalties and requiring a mandatory

13 minimum term of imprisonment and fines based on the

714 xylazinequantity asof a Schedule IIIthe controlled substance; involved in the

15 offense; providing an effective date.

16

17 Be It Enacted by the Legislature of the State of Florida:

18

19 Section 1. Paragraph (c) of subsection (1) of section

20 893.03, Florida Statutes, is amended to read:

821 excepting893.03 Standards fromand theschedules.—The Schedulesubstances III controlled substanceenumerated

9 xylazine specified drug products approved by the

10 United States Food and Drug Administration; defining

11 the term “person”; amending s. 893.13, F.S.; providing

12 criminal penalties and requiring a mandatory minimum

13 term of imprisonment if a person sells, manufactures,

14 or delivers or possesses with intent to sell,

15 manufacture, or deliver xylazine; amending s. 893.135,

16 F.S.; creating the offense of trafficking in xylazine;

17 providing criminal penalties and requiring a mandatory

18 minimum term of imprisonment and fines based on the

19 quantity of the controlled substance involved in the

20 offense; providing an effective date.

21

22 Be It Enacted by the Legislature of the State of Florida:

23

24 Section 1. Paragraph (c) of subsection (1) and paragraph

25 (a) of subsection (3) of section 893.03, Florida Statutes, are

26 amended to read:

27 893.03 Standards and schedules.—The substances enumerated

2822 in this section are controlled by this chapter. The controlled

2923 substances listed or to be listed in Schedules I, II, III, IV,

3024 and V are included by whatever official, common, usual,

3125 chemical, trade name, or class designated. The provisions of

3226 this section shall not be construed to include within any of the

3327 schedules contained in this section any excluded drugs listed

3428 within the purview of 21 C.F.R. s. 1308.22, styled “Excluded

3529 Substances”; 21 C.F.R. s. 1308.24, styled “Exempt Chemical

3630 Preparations”; 21 C.F.R. s. 1308.32, styled “Exempted

3731 Prescription Products”; or 21 C.F.R. s. 1308.34, styled “Exempt

3832 Anabolic Steroid Products.”

3933 (1) SCHEDULE I.—A substance in Schedule I has a high

4034 potential for abuse and has no currently accepted medical use in

4135 treatment in the United States and in its use under medical

4236 supervision does not meet accepted safety standards. The

4337 following substances are controlled in Schedule I:

4438 (c) Unless specifically excepted or unless listed in

4539 another schedule, any material, compound, mixture, or

4640 preparation that contains any quantity of the following

4741 hallucinogenic substances or that contains any of their salts,

4842 isomers, including optical, positional, or geometric isomers,

4943 homologues, nitrogen-heterocyclic analogs, esters, ethers, and

5044 salts of isomers, homologues, nitrogen-heterocyclic analogs,

5145 esters, or ethers, if the existence of such salts, isomers, and

5246 salts of isomers is possible within the specific chemical

5347 designation or class description:

5448 1. Alpha-Ethyltryptamine.

5549 2. 4-Methylaminorex (2-Amino-4-methyl-5-phenyl-2

5650 oxazoline).

5751 3. Aminorex (2-Amino-5-phenyl-2-oxazoline).

5852 4. DOB (4-Bromo-2,5-dimethoxyamphetamine).

5953 5. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).

6054 6. Bufotenine.

6155 7. Cannabis.

6256 8. Cathinone.

6357 9. DET (Diethyltryptamine).

6458 10. 2,5-Dimethoxyamphetamine.

6559 11. DOET (4-Ethyl-2,5-Dimethoxyamphetamine).

6660 12. DMT (Dimethyltryptamine).

6761 13. PCE (N-Ethyl-1-phenylcyclohexylamine) (Ethylamine

6862 analog of phencyclidine).

6963 14. JB-318 (N-Ethyl-3-piperidyl benzilate).

7064 15. N-Ethylamphetamine.

7165 16. Fenethylline.

7266 17. 3,4-Methylenedioxy-N-hydroxyamphetamine.

7367 18. Ibogaine.

7468 19. LSD (Lysergic acid diethylamide).

7569 20. Mescaline.

7670 21. Methcathinone.

7771 22. 5-Methoxy-3,4-methylenedioxyamphetamine.

7872 23. PMA (4-Methoxyamphetamine).

7973 24. PMMA (4-Methoxymethamphetamine).

8074 25. DOM (4-Methyl-2,5-dimethoxyamphetamine).

8175 26. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).

8276 27. MDA (3,4-Methylenedioxyamphetamine).

8377 28. JB-336 (N-Methyl-3-piperidyl benzilate).

8478 29. N,N-Dimethylamphetamine.

8579 30. Parahexyl.

8680 31. Peyote.

8781 32. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine

8882 analog of phencyclidine).

8983 33. Psilocybin.

9084 34. Psilocyn.

9185 35.

Salvia divinorum

, except for any drug product approved

9286 by the United States Food and Drug Administration which contains

93

87

Salvia divinorum

or its isomers, esters, ethers, salts, and

9488 salts of isomers, esters, and ethers, if the existence of such

9589 isomers, esters, ethers, and salts is possible within the

9690 specific chemical designation.

9791 36. Salvinorin A, except for any drug product approved by

9892 the United States Food and Drug Administration which contains

9993 Salvinorin A or its isomers, esters, ethers, salts, and salts of

10094 isomers, esters, and ethers, if the existence of such isomers,

10195 esters, ethers, and salts is possible within the specific

10296 chemical designation.

10397 37. Xylazine

,

, except for anya xylazine animal drug product approved by the

98

approved by the United States Food and Drug Administration, the

99

use of which conforms to the approved application or is

104100

United States Food and Drug Administration which contains

authorized under 21 U.S.C. s. 360b(a)(4). The manufacture,

105101

xylazine or a compounded form of xylazine labeled for veterinary

importation, distribution, prescribing, or sale of xylazine for

106102

use and prescribed or dispensed by a veterinarian licensed under

107

chapter

474

human use is not subject to this exception

.

108103 38. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)

109104 (Thiophene analog of phencyclidine).

110105 39. 3,4,5-Trimethoxyamphetamine.

111106 40. Methylone (3,4-Methylenedioxymethcathinone).

112107 41. MDPV (3,4-Methylenedioxypyrovalerone).

113108 42. Methylmethcathinone.

114109 43. Methoxymethcathinone.

115110 44. Fluoromethcathinone.

116111 45. Methylethcathinone.

117112 46. CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2

118113 yl)phenol) and its dimethyloctyl (C8) homologue.

119114 47. HU-210 [(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2

120115 methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol].

121116 48. JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).

122117 49. JWH-073 (1-Butyl-3-(1-naphthoyl)indole).

123118 50. JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1

124119 naphthoyl)indole).

125120 51. BZP (Benzylpiperazine).

126121 52. Fluorophenylpiperazine.

127122 53. Methylphenylpiperazine.

128123 54. Chlorophenylpiperazine.

129124 55. Methoxyphenylpiperazine.

130125 56. DBZP (1,4-Dibenzylpiperazine).

131126 57. TFMPP (Trifluoromethylphenylpiperazine).

132127 58. MBDB (Methylbenzodioxolylbutanamine) or (3,4

133128 Methylenedioxy-N-methylbutanamine).

134129 59. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).

135130 60. 5-Hydroxy-N-methyltryptamine.

136131 61. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).

137132 62. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).

138133 63. Methyltryptamine.

139134 64. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).

140135 65. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).

141136 66. Tyramine (4-Hydroxyphenethylamine).

142137 67. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).

143138 68. DiPT (N,N-Diisopropyltryptamine).

144139 69. DPT (N,N-Dipropyltryptamine).

145140 70. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).

146141 71. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).

147142 72. DOI (4-Iodo-2,5-dimethoxyamphetamine).

148143 73. DOC (4-Chloro-2,5-dimethoxyamphetamine).

149144 74. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).

150145 75. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).

151146 76. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).

152147 77. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).

153148 78. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).

154149 79. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).

155150 80. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).

156151 81. Butylone (3,4-Methylenedioxy-alpha

157152 methylaminobutyrophenone).

158153 82. Ethcathinone.

159154 83. Ethylone (3,4-Methylenedioxy-N-ethylcathinone).

160155 84. Naphyrone (Naphthylpyrovalerone).

161156 85. Dimethylone (3,4-Methylenedioxy-N,N-dimethylcathinone).

162157 86. 3,4-Methylenedioxy-N,N-diethylcathinone.

163158 87. 3,4-Methylenedioxy-propiophenone.

164159 88. 3,4-Methylenedioxy-alpha-bromopropiophenone.

165160 89. 3,4-Methylenedioxy-propiophenone-2-oxime.

166161 90. 3,4-Methylenedioxy-N-acetylcathinone.

167162 91. 3,4-Methylenedioxy-N-acetylmethcathinone.

168163 92. 3,4-Methylenedioxy-N-acetylethcathinone.

169164 93. Bromomethcathinone.

170165 94. Buphedrone (alpha-Methylamino-butyrophenone).

171166 95. Eutylone (3,4-Methylenedioxy-alpha

172167 ethylaminobutyrophenone).

173168 96. Dimethylcathinone.

174169 97. Dimethylmethcathinone.

175170 98. Pentylone (3,4-Methylenedioxy-alpha

176171 methylaminovalerophenone).

177172 99. MDPPP (3,4-Methylenedioxy-alpha

178173 pyrrolidinopropiophenone).

179174 100. MDPBP (3,4-Methylenedioxy-alpha

180175 pyrrolidinobutyrophenone).

181176 101. MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).

182177 102. MPHP (Methyl-alpha-pyrrolidinohexanophenone).

183178 103. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP

184179 (Benocyclidine).

185180 104. F-MABP (Fluoromethylaminobutyrophenone).

186181 105. MeO-PBP (Methoxypyrrolidinobutyrophenone).

187182 106. Et-PBP (Ethylpyrrolidinobutyrophenone).

188183 107. 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).

189184 108. Me-EABP (Methylethylaminobutyrophenone).

190185 109. Etizolam.

191186 110. PPP (Pyrrolidinopropiophenone).

192187 111. PBP (Pyrrolidinobutyrophenone).

193188 112. PVP (Pyrrolidinovalerophenone) or

194189 (Pyrrolidinopentiophenone).

195190 113. MPPP (Methyl-alpha-pyrrolidinopropiophenone).

196191 114. JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).

197192 115. JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).

198193 116. JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).

199194 117. JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).

200195 118. JWH-072 (1-Propyl-3-(1-naphthoyl)indole).

201196 119. JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).

202197 120. JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).

203198 121. JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan

204199 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).

205200 122. JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).

206201 123. JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).

207202 124. JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).

208203 125. JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).

209204 126. JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).

210205 127. JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).

211206 128. JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).

212207 129. JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).

213208 130. HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3

214209 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1

215210 ol).

216211 131. HU-308 ([(1R,2R,5R)-2-[2,6-Dimethoxy-4-(2-methyloctan

217212 2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]

218213 methanol).

219214 132. HU-331 (3-Hydroxy-2-[(1R,6R)-3-methyl-6-(1

220215 methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene

221216 1,4-dione).

222217 133. CB-13 (4-Pentyloxy-1-(1-naphthoyl)naphthalene).

223218 134. CB-25 (N-Cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)

219 undecanamide).

220 135. CB-52 (N-Cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)

224221 undecanamide).

222 136. CP 55,940 (2-[3-Hydroxy-6-propanol-cyclohexyl]-5-(2

223 methyloctan-2-yl)phenol).

224 137. AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).

225 135138. CB-52AM-2201 (N-Cyclopropyl-111-(2-hexyl-5-hydroxyphenoxy5-Fluoropentyl)-3-(1-naphthoyl)indole).

226 undecanamide).

226 139. RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).

227 136140. CP 55,940RCS-8 (21-[3-Hydroxy-6-propanol-cyclohexyl](2-Cyclohexylethyl)-53-(2

228 methyloctan-2-ylmethoxyphenylacetyl)phenolindole).

229 141. WIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4

230 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1

231 naphthalenylmethanone).

232 142. WIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4

233 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1

234 naphthalenylmethanone).

235 143. Pentedrone (alpha-Methylaminovalerophenone).

229236 137144. AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole)Fluoroamphetamine.

230237 138145. AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole)Fluoromethamphetamine.

238 146. Methoxetamine.

239 147. Methiopropamine.

240 148. Methylbuphedrone (Methyl-alpha

241 methylaminobutyrophenone).

242 149. APB ((2-Aminopropyl)benzofuran).

243 150. APDB ((2-Aminopropyl)-2,3-dihydrobenzofuran).

231244 139151. RCS-4UR-144 (1-Pentyl-3-(4-methoxybenzoyl)indole).2,2,3,3

245 tetramethylcyclopropanoyl)indole).

232246 140152. RCS-8XLR11 (1-(2-Cyclohexylethyl5-Fluoropentyl)-3-(2,2,3,3

247 tetramethylcyclopropanoyl)indole).

248 153. Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3

249 tetramethylcyclopropanoyl)indole).

250 154. AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).

251 155. AM-2233(1-[(N-Methyl-2-piperidinyl)methyl]-3-(2

233252 methoxyphenylacetyliodobenzoyl)indole).

234 141. WIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4

235 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1

253 156. STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3

254 carboxamide).

255 157. URB-597 ((3′-(Aminocarbonyl)[1,1′-biphenyl]-3-yl)

256 cyclohexylcarbamate).

257 158. URB-602 ([1,1′-Biphenyl]-3-yl-carbamic acid,

258 cyclohexyl ester).

259 159. URB-754 (6-Methyl-2-[(4-methylphenyl)amino]-1

236260 naphthalenylmethanonebenzoxazin-4-one).

261 160. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).

262 161. 2C-H (2,5-Dimethoxyphenethylamine).

263 162. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).

264 163. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).

237265 142164. WIN55,212-325I-NBOMe (4-Iodo-2,5-dimethoxy-[(3S)-2,3-Dihydro-5-methyl-3N-(42

238 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1

239 naphthalenylmethanone).

266 methoxybenzyl)]phenethylamine).

240267 143165. PentedroneMDMA (alpha-Methylaminovalerophenone3,4-Methylenedioxymethamphetamine).

268 166. PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).

269 167. Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3

270 carboxylate).

271 168. BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3

272 carboxylate).

241273 144169. Fluoroamphetamine.Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole

274 3-carboxamide).

275 170. AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1

276 pentylindazole-3-carboxamide).

277 171. AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1

278 (4-fluorobenzyl)indazole-3-carboxamide).

279 172. ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)

280 1-pentylindazole-3-carboxamide).

242281 145173. Fluoromethamphetamine.Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2

282 yl)-1-(fluoropentyl)indole-3-carboxamide).

283 174. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2

243 146284 methoxybenzyl)]phenethylamine). Methoxetamine.

244 147. Methiopropamine.

245 148. Methylbuphedrone (Methyl-alpha

285 175. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2

246286 methylaminobutyrophenonemethoxybenzyl)]phenethylamine).

247287 149176. APBAB-CHMINACA (N-(2-Aminopropyl1-Amino-3-methyl-1-oxobutan-2-yl)benzofuran).-1

288 (cyclohexylmethyl)indazole-3-carboxamide).

248289 150177. APDBFUB-PB-22 (8-Quinolinyl 1-(2-Aminopropyl4-fluorobenzyl)-2,3-dihydrobenzofuran).indole-3

290 carboxylate).

291 178. Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole

292 3-carboxamide).

293 179. Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1

294 (fluoropentyl)indazole-3-carboxamide).

295 180. THJ-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indazole).

249296 151181. UR-144AM-855 (1-Pentyl-3(4aR,12bR)-(28-Hexyl-2,25,3,35-trimethyl

250 tetramethylcyclopropanoyl)indole).

251 152. XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3

252 tetramethylcyclopropanoyl)indole).

253 153. Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3

254 tetramethylcyclopropanoyl)indole).

255 154. AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).

297 1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol).

256298 155182. AM-2233AM-905 (1(6aR,9R,10aR)-3-[(N-Methyl-2-piperidinylE)methyl-Hept-1-enyl]-3-(29

257 iodobenzoyl)indole).

258 156. STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3

259 carboxamide).

299 (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a

300 hexahydrobenzo[c]chromen-1-ol).

260301 157183. URB-597AM-906 ((6aR,9R,10aR)-3′-[(AminocarbonylZ)[1,1′-biphenylHept-1-enyl]-3-yl)9

261 cyclohexylcarbamate).

262 158. URB-602 ([1,1′-Biphenyl]-3-yl-carbamic acid,

263 cyclohexyl ester).

302 (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a

303 hexahydrobenzo[c]chromen-1-ol).

304 184. AM-2389 ((6aR,9R,10aR)-3-(1-Hexyl-cyclobut-1-yl)

305 6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9

306 diol).

264307 159185. URB-754HU-243 (6-Methyl-2(6aR,8S,9S,10aR)-[9-(4-methylphenylHydroxymethyl)amino]-16,6

265 benzoxazin-4-one).

308 dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a

309 tetrahydro-6aH-benzo[c]chromen-1-ol).

310 186. HU-336 ((6aR,10aR)-6,6,9-Trimethyl-3-pentyl

311 6a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione).

312 187. MAPB ((2-Methylaminopropyl)benzofuran).

266313 160188. 2C-D5-IT (4-Methyl-2,5-dimethoxyphenethylamine2-(1H-Indol-5-yl)-1-methyl-ethylamine).

267314 161189. 2C-H6-IT (2,5-Dimethoxyphenethylamine-(1H-Indol-6-yl)-1-methyl-ethylamine).

268 162. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).

269 163. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).

270 164. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2

271 methoxybenzyl)]phenethylamine).

272 165. MDMA (3,4-Methylenedioxymethamphetamine).

273 166. PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).

274 167. Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3

275 carboxylate).

276 168. BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3

277 carboxylate).

278 169. Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole

279 3-carboxamide).

280 170. AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1

281 pentylindazole-3-carboxamide).

282 171. AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1

283 (4-fluorobenzyl)indazole-3-carboxamide).

284 172. ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)

285 1-pentylindazole-3-carboxamide).

286 173. Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2

287 yl)-1-(fluoropentyl)indole-3-carboxamide).

288 174. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2

289 methoxybenzyl)]phenethylamine).

290 175. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2

291 methoxybenzyl)]phenethylamine).

292 176. AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1

293 (cyclohexylmethyl)indazole-3-carboxamide).

294 177. FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3

295 carboxylate).

296 178. Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole

297 3-carboxamide).

298 179. Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1

299 (fluoropentyl)indazole-3-carboxamide).

300 180. THJ-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indazole).

301 181. AM-855 ((4aR,12bR)-8-Hexyl-2,5,5-trimethyl

302 1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol).

303 182. AM-905 ((6aR,9R,10aR)-3-[(E)-Hept-1-enyl]-9

304 (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a

305 hexahydrobenzo[c]chromen-1-ol).

306 183. AM-906 ((6aR,9R,10aR)-3-[(Z)-Hept-1-enyl]-9

307 (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a

308 hexahydrobenzo[c]chromen-1-ol).

309 184. AM-2389 ((6aR,9R,10aR)-3-(1-Hexyl-cyclobut-1-yl)

310 6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9

311 diol).

312 185. HU-243 ((6aR,8S,9S,10aR)-9-(Hydroxymethyl)-6,6

313 dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a

314 tetrahydro-6aH-benzo[c]chromen-1-ol).

315 186. HU-336 ((6aR,10aR)-6,6,9-Trimethyl-3-pentyl

316 6a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione).

317 187. MAPB ((2-Methylaminopropyl)benzofuran).

318 188. 5-IT (2-(1H-Indol-5-yl)-1-methyl-ethylamine).

319 189. 6-IT (2-(1H-Indol-6-yl)-1-methyl-ethylamine).

320315 190. Synthetic Cannabinoids.—Unless specifically excepted

321316 or unless listed in another schedule or contained within a

322317 pharmaceutical product approved by the United States Food and

323318 Drug Administration, any material, compound, mixture, or

324319 preparation that contains any quantity of a synthetic

325320 cannabinoid found to be in any of the following chemical class

326321 descriptions, or homologues, nitrogen-heterocyclic analogs,

327322 isomers (including optical, positional, or geometric), esters,

328323 ethers, salts, and salts of homologues, nitrogen-heterocyclic

329324 analogs, isomers, esters, or ethers, whenever the existence of

330325 such homologues, nitrogen-heterocyclic analogs, isomers, esters,

331326 ethers, salts, and salts of isomers, esters, or ethers is

332327 possible within the specific chemical class or designation.

333328 Since nomenclature of these synthetically produced cannabinoids

334329 is not internationally standardized and may continually evolve,

335330 these structures or the compounds of these structures shall be

336331 included under this subparagraph, regardless of their specific

337332 numerical designation of atomic positions covered, if it can be

338333 determined through a recognized method of scientific testing or

339334 analysis that the substance contains properties that fit within

340335 one or more of the following categories:

341336 a. Tetrahydrocannabinols.—Any tetrahydrocannabinols

342337 naturally contained in a plant of the genus

Cannabis

, the

343338 synthetic equivalents of the substances contained in the plant

344339 or in the resinous extracts of the genus

Cannabis

, or synthetic

345340 substances, derivatives, and their isomers with similar chemical

346341 structure and pharmacological activity, including, but not

347342 limited to, Delta 9 tetrahydrocannabinols and their optical

348343 isomers, Delta 8 tetrahydrocannabinols and their optical

349344 isomers, Delta 6a,10a tetrahydrocannabinols and their optical

350345 isomers, or any compound containing a tetrahydrobenzo[c]chromene

351346 structure with substitution at either or both the 3-position or

352347 9-position, with or without substitution at the 1-position with

353348 hydroxyl or alkoxy groups, including, but not limited to:

354349 (I) Tetrahydrocannabinol.

355350 (II) HU-210 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3

356351 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1

357352 ol).

358353 (III) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3

359354 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1

360355 ol).

361356 (IV) JWH-051 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3

362357 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).

363358 (V) JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan

359 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).

360 (VI) JWH-057 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methyloctan

364361 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).

365362 (VIVII) JWH-057JWH-359 ((6aR,10aR)-61-Methoxy-6,6,9-Trimethyl-39-trimethyl-3-(2-methyloctan2,3

363 dimethylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).

364 (VIII) AM-087 ((6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl)

365 6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).

366 (IX) AM-411 ((6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl

366367 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromenechromen-1-ol).

367 (VII) JWH-359 ((6aR,10aR)-1-Methoxy-6,6,9-trimethyl-3-(2,3

368 dimethylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).

369368 (VIIIX) AM-087 ((6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl)Parahexyl.

370 6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).

371 (IX) AM-411 ((6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl

372 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).

373 (X) Parahexyl.

374369 b. Naphthoylindoles, Naphthoylindazoles,

375370 Naphthoylcarbazoles, Naphthylmethylindoles,

376371 Naphthylmethylindazoles, and Naphthylmethylcarbazoles.—Any

377372 compound containing a naphthoylindole, naphthoylindazole,

378373 naphthoylcarbazole, naphthylmethylindole,

379374 naphthylmethylindazole, or naphthylmethylcarbazole structure,

380375 with or without substitution on the indole, indazole, or

381376 carbazole ring to any extent, whether or not substituted on the

382377 naphthyl ring to any extent, including, but not limited to:

383378 (I) JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).

384379 (II) JWH-011 (1-(1-Methylhexyl)-2-methyl-3-(1

385380 naphthoyl)indole).

386381 (III) JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).

387382 (IV) JWH-016 (1-Butyl-2-methyl-3-(1-naphthoyl)indole).

388383 (V) JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).

389384 (VI) JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).

390385 (VII) JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).

391386 (VIII) JWH-022 (1-(4-Pentenyl)-3-(1-naphthoyl)indole).

392387 (IX) JWH-071 (1-Ethyl-3-(1-naphthoyl)indole).

393388 (X) JWH-072 (1-Propyl-3-(1-naphthoyl)indole).

394389 (XI) JWH-073 (1-Butyl-3-(1-naphthoyl)indole).

395390 (XII) JWH-080 (1-Butyl-3-(4-methoxy-1-naphthoyl)indole).

396391 (XIII) JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).

397392 (XIV) JWH-098 (1-Pentyl-2-methyl-3-(4-methoxy-1

398393 naphthoyl)indole).

399394 (XV) JWH-116 (1-Pentyl-2-ethyl-3-(1-naphthoyl)indole).

400395 (XVI) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).

401396 (XVII) JWH-149 (1-Pentyl-2-methyl-3-(4-methyl-1

402397 naphthoyl)indole).

403398 (XVIII) JWH-164 (1-Pentyl-3-(7-methoxy-1-naphthoyl)indole).

404399 (XIX) JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).

405400 (XX) JWH-180 (1-Propyl-3-(4-propyl-1-naphthoyl)indole).

406401 (XXI) JWH-182 (1-Pentyl-3-(4-propyl-1-naphthoyl)indole).

407402 (XXII) JWH-184 (1-Pentyl-3-[(4-methyl)-1

408403 naphthylmethyl]indole).

409404 (XXIII) JWH-193 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methyl-1

410405 naphthoyl)indole).

411406 (XXIV) JWH-198 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methoxy-1

412407 naphthoyl)indole).

413408 (XXV) JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1

409 naphthoyl)indole).

410 (XXVI) JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).

411 (XXVII) JWH-387 (1-Pentyl-3-(4-bromo-1-naphthoyl)indole).

412 (XXVIII) JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).

413 (XXIX) JWH-412 (1-Pentyl-3-(4-fluoro-1-naphthoyl)indole).

414 (XXX) JWH-424 (1-Pentyl-3-(8-bromo-1-naphthoyl)indole).

415 (XXXI) AM-1220 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(1

414416 naphthoyl)indole).

417 (XXXII) AM-1235 (1-(5-Fluoropentyl)-6-nitro-3-(1

418 naphthoyl)indole).

419 (XXXIII) AM-2201 (1-(5-Fluoropentyl)-3-(1

420 naphthoyl)indole).

415421 (XXVIXXXIV) JWH-210Chloro JWH-018 (1-Pentyl-31-(4-ethyl-1-naphthoylChloropentyl)indole).-3-(1

422 naphthoyl)indole).

423 (XXXV) Bromo JWH-018 (1-(Bromopentyl)-3-(1

424 naphthoyl)indole).

416425 (XXVIIXXXVI) JWH-387AM-2232 (1-Pentyl-31-(4-bromo-1-naphthoyl4-Cyanobutyl)-3-(1-naphthoyl)indole).

426 (XXXVII) THJ-2201 (1-(5-Fluoropentyl)-3-(1

427 naphthoyl)indazole).

417428 (XXVIIIXXXVIII) JWH-398MAM-2201 (1-Pentyl-31-(4-chloro-1-naphthoyl5-Fluoropentyl)indole).-3-(4-methyl-1

418 (XXIX) JWH-412 (1-Pentyl-3-(4-fluoro-1-naphthoyl)indole).

419 (XXX) JWH-424 (1-Pentyl-3-(8-bromo-1-naphthoyl)indole).

420 (XXXI) AM-1220 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(1

421 naphthoyl)indole).

422 (XXXII) AM-1235 (1-(5-Fluoropentyl)-6-nitro-3-(1

423 naphthoyl)indole).

424 (XXXIII) AM-2201 (1-(5-Fluoropentyl)-3-(1

425 naphthoyl)indole).

426 (XXXIV) Chloro JWH-018 (1-(Chloropentyl)-3-(1

427 naphthoyl)indole).

428 (XXXV) Bromo JWH-018 (1-(Bromopentyl)-3-(1

429 naphthoyl)indole).

430 (XXXIX) EAM-2201 (1-(5-Fluoropentyl)-3-(4-ethyl-1

431 naphthoyl)indole).

430432 (XXXVIXL) AM-2232EG-018 (1-(4-Cyanobutyl)-39-Pentyl-3-(1-naphthoyl)indolecarbazole).

431433 (XXXVIIXLI) THJ-2201EG-2201 (19-(5-Fluoropentyl)-3-(1

432434 naphthoyl)indazolecarbazole).

435 c. Naphthoylpyrroles.—Any compound containing a

436 naphthoylpyrrole structure, with or without substitution on the

437 pyrrole ring to any extent, whether or not substituted on the

438 naphthyl ring to any extent, including, but not limited to:

433439 (XXXVIIII) MAM-2201JWH-030 (11-Pentyl-3-(5-Fluoropentyl1-naphthoyl)-3-(4-methyl-1pyrrole).

440 (II) JWH-031 (1-Hexyl-3-(1-naphthoyl)pyrrole).

441 (III) JWH-145 (1-Pentyl-5-phenyl-3-(1-naphthoyl)pyrrole).

442 (IV) JWH-146 (1-Heptyl-5-phenyl-3-(1-naphthoyl)pyrrole).

443 (V) JWH-147 (1-Hexyl-5-phenyl-3-(1-naphthoyl)pyrrole).

444 (VI) JWH-307 (1-Pentyl-5-(2-fluorophenyl)-3-(1

434445 naphthoyl)indolepyrrole).

446 (VII) JWH-309 (1-Pentyl-5-(1-naphthalenyl)-3-(1

447 naphthoyl)pyrrole).

448 (VIII) JWH-368 (1-Pentyl-5-(3-fluorophenyl)-3-(1

449 naphthoyl)pyrrole).

435450 (XXXIXIX) EAM-2201JWH-369 (11-Pentyl-5-(5-Fluoropentyl2-chlorophenyl)-3-(4-ethyl-11

451 naphthoyl)pyrrole).

452 (X) JWH-370 (1-Pentyl-5-(2-methylphenyl)-3-(1

436453 naphthoyl)indolepyrrole).

454 d. Naphthylmethylenindenes.—Any compound containing a

455 naphthylmethylenindene structure, with or without substitution

456 at the 3-position of the indene ring to any extent, whether or

457 not substituted on the naphthyl ring to any extent, including,

458 but not limited to, JWH-176 (3-Pentyl-1

459 (naphthylmethylene)indene).

437460 (XL)e. EG-018Phenylacetylindoles (9-Pentyl-3-(1-naphthoyl)carbazole)and Phenylacetylindazoles.—Any

461 compound containing a phenylacetylindole or phenylacetylindazole

462 structure, with or without substitution on the indole or

463 indazole ring to any extent, whether or not substituted on the

464 phenyl ring to any extent, including, but not limited to:

438465 (XLII) EG-2201JWH-167 (91-Pentyl-3-(5-Fluoropentylphenylacetyl)-3-(1indole).

466 (II) JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).

467 (III) JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).

468 (IV) JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).

469 (V) JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).

470 (VI) JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).

471 (VII) Cannabipiperidiethanone.

472 (VIII) RCS-8 (1-(2-Cyclohexylethyl)-3-(2

439473 naphthoylmethoxyphenylacetyl)carbazoleindole).

440474 cf. NaphthoylpyrrolesCyclohexylphenols.—Any compound containing a

441475 naphthoylpyrrolecyclohexylphenol structure, with or without substitution onat the

442476 pyrrole5-position of the phenolic ring to any extent, whether or not substituted on the

443477 naphthylsubstituted on the cyclohexyl ring to any extent, including, but not limited to:

444 (I) JWH-030 (1-Pentyl-3-(1-naphthoyl)pyrrole).

478 not limited to:

445479 (III) JWH-031CP 47,497 (1-Hexyl-32-(1-naphthoyl3-Hydroxycyclohexyl)pyrrole).-5-(2-methyloctan-2

446 (III) JWH-145 (1-Pentyl-5-phenyl-3-(1-naphthoyl)pyrrole).

447 (IV) JWH-146 (1-Heptyl-5-phenyl-3-(1-naphthoyl)pyrrole).

448 (V) JWH-147 (1-Hexyl-5-phenyl-3-(1-naphthoyl)pyrrole).

449 (VI) JWH-307 (1-Pentyl-5-(2-fluorophenyl)-3-(1

450480 naphthoylyl)pyrrolephenol).

451 (VII) JWH-309 (1-Pentyl-5-(1-naphthalenyl)-3-(1

481 (II) Cannabicyclohexanol (CP 47,497 dimethyloctyl (C8)

452482 naphthoyl)pyrrolehomologue).

483 (III) CP-55,940 (2-(3-Hydroxy-6-propanol-cyclohexyl)-5-(2

484 methyloctan-2-yl)phenol).

485 g. Benzoylindoles and Benzoylindazoles.—Any compound

486 containing a benzoylindole or benzoylindazole structure, with or

487 without substitution on the indole or indazole ring to any

488 extent, whether or not substituted on the phenyl ring to any

489 extent, including, but not limited to:

453490 (VIIII) JWH-368AM-679 (1-Pentyl-51-Pentyl-3-(3-fluorophenyl2-iodobenzoyl)-3-(1indole).

491 (II) AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).

492 (III) AM-1241 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2

493 iodo-5-nitrobenzoyl)indole).

494 (IV) Pravadoline (1-[2-(4-Morpholinyl)ethyl]-2-methyl-3-(4

454495 naphthoylmethoxybenzoyl)pyrroleindole).

496 (V) AM-2233 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2

497 iodobenzoyl)indole).

455498 (IXVI) JWH-369RCS-4 (1-Pentyl-51-Pentyl-3-(2-chlorophenyl4-methoxybenzoyl)-3-(1indole).

456 naphthoyl)pyrrole).

457499 (XVII) JWH-370RCS-4 C4 homologue (1-Pentyl-51-Butyl-3-(2-methylphenyl)-3-(14

458 naphthoyl)pyrrole).

459 d. Naphthylmethylenindenes.—Any compound containing a

460 naphthylmethylenindene structure, with or without substitution

461 at the 3-position of the indene ring to any extent, whether or

462 not substituted on the naphthyl ring to any extent, including,

463 but not limited to, JWH-176 (3-Pentyl-1

464 (naphthylmethylene)indene).

465 e. Phenylacetylindoles and Phenylacetylindazoles.—Any

466 compound containing a phenylacetylindole or phenylacetylindazole

467 structure, with or without substitution on the indole or

468 indazole ring to any extent, whether or not substituted on the

469 phenyl ring to any extent, including, but not limited to:

470 (I) JWH-167 (1-Pentyl-3-(phenylacetyl)indole).

471 (II) JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).

472 (III) JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).

473 (IV) JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).

474 (V) JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).

475 (VI) JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).

476 (VII) Cannabipiperidiethanone.

477 (VIII) RCS-8 (1-(2-Cyclohexylethyl)-3-(2

478 methoxyphenylacetyl)indole).

479 f. Cyclohexylphenols.—Any compound containing a

480 cyclohexylphenol structure, with or without substitution at the

481 5-position of the phenolic ring to any extent, whether or not

482 substituted on the cyclohexyl ring to any extent, including, but

483 not limited to:

484 (I) CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2

485 yl)phenol).

486 (II) Cannabicyclohexanol (CP 47,497 dimethyloctyl (C8)

487 homologue).

488 (III) CP-55,940 (2-(3-Hydroxy-6-propanol-cyclohexyl)-5-(2

489 methyloctan-2-yl)phenol).

490 g. Benzoylindoles and Benzoylindazoles.—Any compound

491 containing a benzoylindole or benzoylindazole structure, with or

492 without substitution on the indole or indazole ring to any

493 extent, whether or not substituted on the phenyl ring to any

494 extent, including, but not limited to:

495 (I) AM-679 (1-Pentyl-3-(2-iodobenzoyl)indole).

496 (II) AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).

497 (III) AM-1241 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2

498 iodo-5-nitrobenzoyl)indole).

499 (IV) Pravadoline (1-[2-(4-Morpholinyl)ethyl]-2-methyl-3-(4

500 methoxybenzoyl)indole).

501 (VVIII) AM-2233AM-630 (1-[2-(N-Methyl-2-piperidinyl4-Morpholinyl)methylethyl]-3-(22-methyl-6-iodo

502 iodobenzoyl3-(4-methoxybenzoyl)indole).

503 h. Tetramethylcyclopropanoylindoles and

504 Tetramethylcyclopropanoylindazoles.—Any compound containing a

505 tetramethylcyclopropanoylindole or

506 tetramethylcyclopropanoylindazole structure, with or without

507 substitution on the indole or indazole ring to any extent,

508 whether or not substituted on the tetramethylcyclopropyl group

509 to any extent, including, but not limited to:

503510 (VII) RCS-4UR-144 (1-Pentyl-3-(4-methoxybenzoyl)indole).2,2,3,3

511 tetramethylcyclopropanoyl)indole).

512 (II) XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3

513 tetramethylcyclopropanoyl)indole).

504514 (VIIIII) RCS-4Chloro C4 homologueUR-144 (1-Butyl-31-(4Chloropentyl)-3-(2,2,3,3

505515 methoxybenzoyltetramethylcyclopropanoyl)indole).

506516 (VIIIIV) AM-630A-796,260 (1-[2-(4-Morpholinyl)ethyl]-2-methyl-6-iodo3-(2,2,3,3

507517 3-(4-methoxybenzoyltetramethylcyclopropanoyl)indole).

518 (V) A-834,735 (1-[4-(Tetrahydropyranyl)methyl]-3-(2,2,3,3

508 h519 tetramethylcyclopropanoyl)indole). Tetramethylcyclopropanoylindoles and

520 (VI) M-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3

521 tetramethylcyclopropanoyl)indole).

522 (VII) FUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3

523 tetramethylcyclopropanoyl)indole).

524 (VIII) FAB-144 (1-(5-Fluoropentyl)-3-(2,2,3,3

509525 Tetramethylcyclopropanoylindazolestetramethylcyclopropanoyl)indazole).—Any compound containing a

526 (IX) XLR12 (1-(4,4,4-Trifluorobutyl)-3-(2,2,3,3

510527 tetramethylcyclopropanoylindole ortetramethylcyclopropanoyl)indole).

528 (X) AB-005 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(2,2,3,3

511529 tetramethylcyclopropanoylindazole structure, with or withouttetramethylcyclopropanoyl)indole).

530 i. Adamantoylindoles, Adamantoylindazoles, Adamantylindole

531 carboxamides, and Adamantylindazole carboxamides.—Any compound

532 containing an adamantoyl indole, adamantoyl indazole, adamantyl

533 indole carboxamide, or adamantyl indazole carboxamide structure,

512534 with or without substitution on the indole or indazole ring to any extent,

513535 any extent, whether or not substituted on the tetramethylcyclopropyladamantyl groupring to

514536 to any extent, including, but not limited to:

537 (I) AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).

538 (II) Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole

539 3-carboxamide).

540 (III) STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3

541 carboxamide).

515542 (IIV) UR-144AM-1248 (1-Pentyl-31-(2,2,3,31-Methylpiperidine)methyl-3-(1

516543 tetramethylcyclopropanoyladamantoyl)indole).

544 (V) AB-001 (1-Pentyl-3-(1-adamantoyl)indole).

545 (VI) APICA (N-Adamant-1-yl 1-pentylindole-3-carboxamide).

517546 (IIVII) XLR11Fluoro AB-001 (1-(5-FluoropentylFluoropentyl)-3-(2,2,3,31

518547 tetramethylcyclopropanoyladamantoyl)indole).

519 (III) Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3

520 tetramethylcyclopropanoyl)indole).

521 (IV) A-796,260 (1-[2-(4-Morpholinyl)ethyl]-3-(2,2,3,3

522 tetramethylcyclopropanoyl)indole).

523 (V) A-834,735 (1-[4-(Tetrahydropyranyl)methyl]-3-(2,2,3,3

524 tetramethylcyclopropanoyl)indole).

525 (VI) M-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3

526 tetramethylcyclopropanoyl)indole).

527 (VII) FUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3

528 tetramethylcyclopropanoyl)indole).

529 (VIII) FAB-144 (1-(5-Fluoropentyl)-3-(2,2,3,3

530 tetramethylcyclopropanoyl)indazole).

531 (IX) XLR12 (1-(4,4,4-Trifluorobutyl)-3-(2,2,3,3

532 tetramethylcyclopropanoyl)indole).

533 (X) AB-005 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(2,2,3,3

534 tetramethylcyclopropanoyl)indole).

535548 ij. AdamantoylindolesQuinolinylindolecarboxylates, Adamantoylindazoles, Adamantylindole

549 Quinolinylindazolecarboxylates, Quinolinylindolecarboxamides,

550 and Quinolinylindazolecarboxamides.—Any compound containing a

551 quinolinylindole carboxylate, quinolinylindazole carboxylate,

552 isoquinolinylindole carboxylate, isoquinolinylindazole

553 carboxylate, quinolinylindole carboxamide, quinolinylindazole

536554 carboxamidescarboxamide, andisoquinolinylindole Adamantylindazolecarboxamide, carboxamides.—Any compoundor

555 isoquinolinylindazole carboxamide structure, with or without

537556 containingsubstitution anon adamantoylthe indole, adamantoylor indazole ring to any extent, adamantyl

538 indole carboxamide, or adamantyl indazole carboxamide structure,

539557 withwhether or withoutnot substitutionsubstituted on the indolequinoline or indazoleisoquinoline ring to

540558 to any extent, whetherincluding, orbut not substituted on the adamantyl ringlimited to:

541 any extent, including, but not limited to:

542559 (I) AKB48PB-22 (N-Adamant-1-yl8-Quinolinyl 1-pentylindazole-3-carboxamide1-pentylindole-3-carboxylate).

560 (II) Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3

561 carboxylate).

562 (III) BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3

563 carboxylate).

564 (IV) FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3

565 carboxylate).

566 (V) NPB-22 (8-Quinolinyl 1-pentylindazole-3-carboxylate).

543567 (IIVI) Fluoro AKB48NPB-22 (N-Adamant-1-yl8-Quinolinyl 1-(fluoropentyl)indazole

568 3-carboxylate).

569 (VII) FUB-NPB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indazole

570 3-carboxylate).

571 (VIII) THJ (8-Quinolinyl 1-pentylindazole-3-carboxamide).

572 (IX) Fluoro THJ (8-Quinolinyl 1-(fluoropentyl)indazole-3

544573 3-carboxamidecarboxamide).

574 k. Naphthylindolecarboxylates and

575 Naphthylindazolecarboxylates.—Any compound containing a

576 naphthylindole carboxylate or naphthylindazole carboxylate

577 structure, with or without substitution on the indole or

578 indazole ring to any extent, whether or not substituted on the

579 naphthyl ring to any extent, including, but not limited to:

545580 (IIII) STS-135NM-2201 (N-Adamant-1-yl1-Naphthalenyl 1-(5-fluoropentyl)indole-3

546581 carboxamidecarboxylate).

547582 (IVII) AM-1248SDB-005 (1-(1-Methylpiperidine)methyl-3-(11-Naphthalenyl 1-pentylindazole-3

548583 adamantoyl)indolecarboxylate).

584 (III) Fluoro SDB-005 (1-Naphthalenyl 1

585 (fluoropentyl)indazole-3-carboxylate).

549586 (VIV) AB-001FDU-PB-22 (1-Pentyl-31-Naphthalenyl 1-(1-adamantoyl4-fluorobenzyl)indole).indole-3

587 carboxylate).

550588 (VIV) APICA3-CAF (N-Adamant-1-yl2-Naphthalenyl 1-pentylindole-3-carboxamide1-(2-fluorophenyl).indazole-3

589 carboxylate).

590 l. Naphthylindole carboxamides and Naphthylindazole

591 carboxamides.—Any compound containing a naphthylindole

592 carboxamide or naphthylindazole carboxamide structure, with or

593 without substitution on the indole or indazole ring to any

594 extent, whether or not substituted on the naphthyl ring to any

595 extent, including, but not limited to:

551596 (VIII) Fluoro AB-001NNEI (1-(FluoropentylN-Naphthalen-1-yl 1-pentylindole-3-carboxamide)-3-(1.

597 (II) Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole

598 3-carboxamide).

599 (III) Chloro-NNEI (N-Naphthalen-1-yl 1

600 (chloropentyl)indole-3-carboxamide).

601 (IV) MN-18 (N-Naphthalen-1-yl 1-pentylindazole-3

552602 adamantoyl)indolecarboxamide).

603 (V) Fluoro MN-18 (N-Naphthalen-1-yl 1

604 (fluoropentyl)indazole-3-carboxamide).

553605 jm. QuinolinylindolecarboxylatesAlkylcarbonyl indole carboxamides, Alkylcarbonyl

606 indazole carboxamides, Alkylcarbonyl indole carboxylates, and

607 Alkylcarbonyl indazole carboxylates.—Any compound containing an

608 alkylcarbonyl group, including 1-amino-3-methyl-1-oxobutan-2-yl,

609 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3

610 phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an

611 indole carboxamide, indazole carboxamide, indole carboxylate, or

554612 Quinolinylindazolecarboxylatesindazole carboxylate, Quinolinylindolecarboxamides,with or without substitution on the indole

613 or indazole ring to any extent, whether or not substituted on

614 the alkylcarbonyl group to any extent, including, but not

615 limited to:

616 (I) ADBICA, (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1

555617 and Quinolinylindazolecarboxamidespentylindole-3-carboxamide).—Any compound containing a

618 (II) Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2

619 yl)-1-(fluoropentyl)indole-3-carboxamide).

620 (III) Fluoro ABICA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1

621 (fluoropentyl)indole-3-carboxamide).

622 (IV) AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1

556623 quinolinylindole carboxylate, quinolinylindazole carboxylate,pentylindazole-3-carboxamide).

557 isoquinolinylindole carboxylate, isoquinolinylindazole

558 carboxylate, quinolinylindole carboxamide, quinolinylindazole

559 carboxamide, isoquinolinylindole carboxamide, or

624 (V) Fluoro AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)

625 1-(fluoropentyl)indazole-3-carboxamide).

626 (VI) ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)

560627 isoquinolinylindazole carboxamide structure, with or without1-pentylindazole-3-carboxamide).

561 substitution on the indole or indazole ring to any extent,

562 whether or not substituted on the quinoline or isoquinoline ring

563 to any extent, including, but not limited to:

628 (VII) Fluoro ADB-PINACA (N-(1-Amino-3,3-dimethyl-1

564 629 oxobutan-2-yl)-1-(Ifluoropentyl) PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylateindazole-3-carboxamide).

565630 (IIVIII) Fluoro PB-22AB-FUBINACA (8-Quinolinyl 1N-(fluoropentyl1-Amino-3-methyl-1-oxobutan-2-yl)indole-3-1

566 carboxylate).

631 (4-fluorobenzyl)indazole-3-carboxamide).

632 (IX) ADB-FUBINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2

633 yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).

634 (X) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1

635 (cyclohexylmethyl)indazole-3-carboxamide).

636 (XI) MA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1

567 (III) BB-22 (8-Quinolinyl 1-637 (cyclohexylmethyl)indole-3indazole-3-carboxamide).

638 (XII) MAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2

639 yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).

640 (XIII) AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1

568641 carboxylatepentylindazole-3-carboxamide).

642 (XIV) Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1

643 (fluoropentyl)indazole-3-carboxamide).

644 (XV) FUB-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4

645 fluorobenzyl)indazole-3-carboxamide).

646 (XVI) MDMB-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan

647 2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).

648 (XVII) MDMB-FUBINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan

569 (IV649 2-yl) FUB-PB-22 (8-Quinolinyl -1-(4-fluorobenzyl)indole-3indazole-3-carboxamide).

570 carboxylate).

650 (XVIII) MDMB-CHMICA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan

651 2-yl)-1-(cyclohexylmethyl)indole-3-carboxamide).

652 (XIX) PX-1 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5

653 fluoropentyl)indole-3-carboxamide).

654 (XX) PX-2 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5

571 (V655 fluoropentyl) NPB-22 (8-Quinolinyl 1-pentylindazole-3-carboxylateindazole-3-carboxamide).

572656 (VIXXI) Fluoro NPB-22PX-3 (8-Quinolinyl 1N-(fluoropentyl1-Amino-1-oxo-3-phenylpropan-2-yl)indazole-1

657 (cyclohexylmethyl)indazole-3-carboxamide).

658 (XXII) PX-4 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(4

573659 3-carboxylatefluorobenzyl)indazole-3-carboxamide).

574 (VII) FUB-NPB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indazole

660 (XXIII) MO-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan

575661 3-carboxylate2-yl)-1-(cyclohexylmethyl)indazole-3-carboxylate).

662 n. Cumylindolecarboxamides and Cumylindazolecarboxamides.

663 Any compound containing a N-(2-phenylpropan-2-yl) indole

664 carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide

665 structure, with or without substitution on the indole or

666 indazole ring to any extent, whether or not substituted on the

667 phenyl ring of the cumyl group to any extent, including, but not

668 limited to:

576669 (VIIII) THJCUMYL-PICA (8-Quinolinyl 1-pentylindazole-3-carboxamideN-(2-Phenylpropan-2-yl).-1-pentylindole-3

670 carboxamide).

577671 (IXII) Fluoro THJCUMYL-PICA (8-Quinolinyl 1N-(fluoropentyl2-Phenylpropan-2-yl)indazole-3-1

578672 carboxamide(fluoropentyl)indole-3-carboxamide).

579 k. Naphthylindolecarboxylates and

580 Naphthylindazolecarboxylates.—Any compound containing a

581 naphthylindole carboxylate or naphthylindazole carboxylate

673 o. Other Synthetic Cannabinoids.—Any material, compound,

674 mixture, or preparation that contains any quantity of a

675 Synthetic Cannabinoid, as described in sub-subparagraphs a.-n.:

676 (I) With or without modification or replacement of a

677 carbonyl, carboxamide, alkylene, alkyl, or carboxylate linkage

678 between either two core rings, or linkage between a core ring

582679 and group structure, with or without substitution on the indoleaddition of a carbon or

680 replacement of a carbon;

681 (II) With or without replacement of a core ring or group

583682 indazole ring to any extentstructure, whether or not substituted on the ring or group

584 naphthyl ring to any extent, including, but not limited to:

585 (I) NM-2201 (1-Naphthalenyl 1-(5-fluoropentyl)indole-3

586 carboxylate).

587 (II) SDB-005 (1-Naphthalenyl 1-pentylindazole-3

588 carboxylate).

589 (III) Fluoro SDB-005 (1-Naphthalenyl 1

590 (fluoropentyl)indazole-3-carboxylate).

591 (IV) FDU-PB-22 (1-Naphthalenyl 1-(4-fluorobenzyl)indole-3

592 carboxylate).

593 (V) 3-CAF (2-Naphthalenyl 1-(2-fluorophenyl)indazole-3

594 carboxylate).

595 l. Naphthylindole carboxamides and Naphthylindazole

596 carboxamides.—Any compound containing a naphthylindole

597 carboxamide or naphthylindazole carboxamide structure, with or

598 without substitution on the indole or indazole ring to any

599 extent, whether or not substituted on the naphthyl ring to any

600 extent, including, but not limited to:

601 (I) NNEI (N-Naphthalen-1-yl 1-pentylindole-3-carboxamide).

602 (II) Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole

603 3-carboxamide).

604 (III) Chloro-NNEI (N-Naphthalen-1-yl 1

605 (chloropentyl)indole-3-carboxamide).

606 (IV) MN-18 (N-Naphthalen-1-yl 1-pentylindazole-3

607 carboxamide).

608 (V) Fluoro MN-18 (N-Naphthalen-1-yl 1

609 (fluoropentyl)indazole-3-carboxamide).

610 m. Alkylcarbonyl indole carboxamides, Alkylcarbonyl

611 indazole carboxamides, Alkylcarbonyl indole carboxylates, and

612 Alkylcarbonyl indazole carboxylates.—Any compound containing an

613 alkylcarbonyl group, including 1-amino-3-methyl-1-oxobutan-2-yl,

614 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3

615 phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an

616 indole carboxamide, indazole carboxamide, indole carboxylate, or

617 indazole carboxylate, with or without substitution on the indole

618683 or indazole ringstructures to any extent,; whether or not substituted onand

619 the alkylcarbonyl group to any extent, including, but not

620 limited to:

621 (I) ADBICA, (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1

622 pentylindole-3-carboxamide).

623 (II) Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2

624 yl)-1-(fluoropentyl)indole-3-carboxamide).

625 (III) Fluoro ABICA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1

626 (fluoropentyl)indole-3-carboxamide).

627 (IV) AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1

628 pentylindazole-3-carboxamide).

629 (V) Fluoro AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)

630 1-(fluoropentyl)indazole-3-carboxamide).

631 (VI) ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)

632 1-pentylindazole-3-carboxamide).

633 (VII) Fluoro ADB-PINACA (N-(1-Amino-3,3-dimethyl-1

634 oxobutan-2-yl)-1-(fluoropentyl)indazole-3-carboxamide).

635 (VIII) AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1

636 (4-fluorobenzyl)indazole-3-carboxamide).

637 (IX) ADB-FUBINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2

638 yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).

639 (X) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1

640 (cyclohexylmethyl)indazole-3-carboxamide).

641 (XI) MA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1

642 (cyclohexylmethyl)indazole-3-carboxamide).

643 (XII) MAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2

644 yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).

645 (XIII) AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1

646 pentylindazole-3-carboxamide).

647 (XIV) Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1

648 (fluoropentyl)indazole-3-carboxamide).

649 (XV) FUB-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4

650 fluorobenzyl)indazole-3-carboxamide).

651 (XVI) MDMB-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan

652 2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).

653 (XVII) MDMB-FUBINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan

654 2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).

655 (XVIII) MDMB-CHMICA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan

656 2-yl)-1-(cyclohexylmethyl)indole-3-carboxamide).

657 (XIX) PX-1 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5

658 fluoropentyl)indole-3-carboxamide).

659 (XX) PX-2 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5

660 fluoropentyl)indazole-3-carboxamide).

661 (XXI) PX-3 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1

662 (cyclohexylmethyl)indazole-3-carboxamide).

663 (XXII) PX-4 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(4

664 fluorobenzyl)indazole-3-carboxamide).

665 (XXIII) MO-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan

666 2-yl)-1-(cyclohexylmethyl)indazole-3-carboxylate).

667 n. Cumylindolecarboxamides and Cumylindazolecarboxamides.

668 Any compound containing a N-(2-phenylpropan-2-yl) indole

669 carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide

670 structure, with or without substitution on the indole or

671 indazole ring to any extent, whether or not substituted on the

672 phenyl ring of the cumyl group to any extent, including, but not

673 limited to:

674 (I) CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-pentylindole-3

675 carboxamide).

676 (II) Fluoro CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1

677 (fluoropentyl)indole-3-carboxamide).

678684 o.(III) OtherIs Synthetica Cannabinoids.—Anycannabinoid materialreceptor agonist, compound,unless

679 mixture, or preparation that contains any quantity of a

680 Synthetic Cannabinoid, as described in sub-subparagraphs a.-n.:

681 (I) With or without modification or replacement of a

682 carbonyl, carboxamide, alkylene, alkyl, or carboxylate linkage

685 specifically excepted or unless listed in another schedule or

686 contained within a pharmaceutical product approved by the United

687 States Food and Drug Administration.

688 191. Substituted Cathinones.—Unless specifically excepted,

683689 betweenlisted eitherin twoanother core ringsschedule, or linkagecontained betweenwithin a core ringpharmaceutical

684 and group structure, with or without the addition of a carbon or

685 replacement of a carbon;

686 (II) With or without replacement of a core ring or group

687 structure, whether or not substituted on the ring or group

690 product approved by the United States Food and Drug

691 Administration, any material, compound, mixture, or preparation,

692 including its salts, isomers, esters, or ethers, and salts of

693 isomers, esters, or ethers, whenever the existence of such salts

694 is possible within any of the following specific chemical

695 designations:

696 a. Any compound containing a 2-amino-1-phenyl-1-propanone

688697 structures to any extentstructure; and

689 (III) Is a cannabinoid receptor agonist, unless

690 specifically excepted or unless listed in another schedule or

691 contained within a pharmaceutical product approved by the United

692 States Food and Drug Administration.

693 191. Substituted Cathinones.—Unless specifically excepted,

694 listed in another schedule, or contained within a pharmaceutical

695 product approved by the United States Food and Drug

696 Administration, any material, compound, mixture, or preparation,

697 including its salts, isomers, esters, or ethers, and salts of

698 isomers, esters, or ethers, whenever the existence of such salts

699 is possible within any of the following specific chemical

700 designations:

701698 ab. Any compound containing a 2-amino-1-phenyl-1-propanone2-amino-1-naphthyl-1-propanone

702699 structure; or

703700 bc. Any compound containing a 2-amino-1-naphthyl-1-propanone2-amino-1-thiophenyl-1

704701 propanone structure; or,

705 c. Any compound containing a 2-amino-1-thiophenyl-1

706 propanone structure,

707702

708703 whether or not the compound is further modified:

709704 (I) With or without substitution on the ring system to any

710705 extent with alkyl, alkylthio, thio, fused alkylenedioxy, alkoxy,

711706 haloalkyl, hydroxyl, nitro, fused furan, fused benzofuran, fused

712707 dihydrofuran, fused tetrahydropyran, fused alkyl ring, or halide

713708 substituents;

714709 (II) With or without substitution at the 3-propanone

715710 position with an alkyl substituent or removal of the methyl

716711 group at the 3-propanone position;

717712 (III) With or without substitution at the 2-amino nitrogen

718713 atom with alkyl, dialkyl, acetyl, or benzyl groups, whether or

719714 not further substituted in the ring system; or

720715 (IV) With or without inclusion of the 2-amino nitrogen atom

721716 in a cyclic structure, including, but not limited to:

722717 (A) Methcathinone.

723718 (B) Ethcathinone.

724719 (C) Methylone (3,4-Methylenedioxymethcathinone).

725720 (D) 2,3-Methylenedioxymethcathinone.

726721 (E) MDPV (3,4-Methylenedioxypyrovalerone).

727722 (F) Methylmethcathinone.

728723 (G) Methoxymethcathinone.

729724 (H) Fluoromethcathinone.

730725 (I) Methylethcathinone.

731726 (J) Butylone (3,4-Methylenedioxy-alpha

732727 methylaminobutyrophenone).

733728 (K) Ethylone (3,4-Methylenedioxy-N-ethylcathinone).

734729 (L) BMDP (3,4-Methylenedioxy-N-benzylcathinone).

735730 (M) Naphyrone (Naphthylpyrovalerone).

736731 (N) Bromomethcathinone.

737732 (O) Buphedrone (alpha-Methylaminobutyrophenone).

738733 (P) Eutylone (3,4-Methylenedioxy-alpha

739734 ethylaminobutyrophenone).

740735 (Q) Dimethylcathinone.

741736 (R) Dimethylmethcathinone.

742737 (S) Pentylone (3,4-Methylenedioxy-alpha

743738 methylaminovalerophenone).

744739 (T) Pentedrone (alpha-Methylaminovalerophenone).

745740 (U) MDPPP (3,4-Methylenedioxy-alpha

746741 pyrrolidinopropiophenone).

747742 (V) MDPBP (3,4-Methylenedioxy-alpha

748743 pyrrolidinobutyrophenone).

749744 (W) MPPP (Methyl-alpha-pyrrolidinopropiophenone).

750745 (X) PPP (Pyrrolidinopropiophenone).

751746 (Y) PVP (Pyrrolidinovalerophenone) or

752747 (Pyrrolidinopentiophenone).

753748 (Z) MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).

754749 (AA) MPHP (Methyl-alpha-pyrrolidinohexanophenone).

755750 (BB) F-MABP (Fluoromethylaminobutyrophenone).

756751 (CC) Me-EABP (Methylethylaminobutyrophenone).

757752 (DD) PBP (Pyrrolidinobutyrophenone).

758753 (EE) MeO-PBP (Methoxypyrrolidinobutyrophenone).

759754 (FF) Et-PBP (Ethylpyrrolidinobutyrophenone).

760755 (GG) 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).

761756 (HH) Dimethylone (3,4-Methylenedioxy-N,N

762757 dimethylcathinone).

763758 (II) 3,4-Methylenedioxy-N,N-diethylcathinone.

764759 (JJ) 3,4-Methylenedioxy-N-acetylcathinone.

765760 (KK) 3,4-Methylenedioxy-N-acetylmethcathinone.

766761 (LL) 3,4-Methylenedioxy-N-acetylethcathinone.

767762 (MM) Methylbuphedrone (Methyl-alpha

768763 methylaminobutyrophenone).

769764 (NN) Methyl-alpha-methylaminohexanophenone.

770765 (OO) N-Ethyl-N-methylcathinone.

771766 (PP) PHP (Pyrrolidinohexanophenone).

772767 (QQ) PV8 (Pyrrolidinoheptanophenone).

773768 (RR) Chloromethcathinone.

774769 (SS) 4-Bromo-2,5-dimethoxy-alpha-aminoacetophenone.

775770 192. Substituted Phenethylamines.—Unless specifically

776771 excepted or unless listed in another schedule, or contained

777772 within a pharmaceutical product approved by the United States

778773 Food and Drug Administration, any material, compound, mixture,

779774 or preparation, including its salts, isomers, esters, or ethers,

780775 and salts of isomers, esters, or ethers, whenever the existence

781776 of such salts is possible within any of the following specific

782777 chemical designations, any compound containing a phenethylamine

783778 structure, without a beta-keto group, and without a benzyl group

784779 attached to the amine group, whether or not the compound is

785780 further modified with or without substitution on the phenyl ring

786781 to any extent with alkyl, alkylthio, nitro, alkoxy, thio,

787782 halide, fused alkylenedioxy, fused furan, fused benzofuran,

788783 fused dihydrofuran, or fused tetrahydropyran substituents,

789784 whether or not further substituted on a ring to any extent, with

790785 or without substitution at the alpha or beta position by any

791786 alkyl substituent, with or without substitution at the nitrogen

792787 atom, and with or without inclusion of the 2-amino nitrogen atom

793788 in a cyclic structure, including, but not limited to:

794789 a. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).

795790 b. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).

796791 c. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).

797792 d. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).

798793 e. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).

799794 f. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).

800795 g. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).

801796 h. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).

802797 i. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).

803798 j. 2C-H (2,5-Dimethoxyphenethylamine).

804799 k. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).

805800 l. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).

806801 m. MDMA (3,4-Methylenedioxymethamphetamine).

807802 n. MBDB (Methylbenzodioxolylbutanamine) or (3,4

808803 Methylenedioxy-N-methylbutanamine).

809804 o. MDA (3,4-Methylenedioxyamphetamine).

810805 p. 2,5-Dimethoxyamphetamine.

811806 q. Fluoroamphetamine.

812807 r. Fluoromethamphetamine.

813808 s. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).

814809 t. DOB (4-Bromo-2,5-dimethoxyamphetamine).

815810 u. DOC (4-Chloro-2,5-dimethoxyamphetamine).

816811 v. DOET (4-Ethyl-2,5-dimethoxyamphetamine).

817812 w. DOI (4-Iodo-2,5-dimethoxyamphetamine).

818813 x. DOM (4-Methyl-2,5-dimethoxyamphetamine).

819814 y. PMA (4-Methoxyamphetamine).

820815 z. N-Ethylamphetamine.

821816 aa. 3,4-Methylenedioxy-N-hydroxyamphetamine.

822817 bb. 5-Methoxy-3,4-methylenedioxyamphetamine.

823818 cc. PMMA (4-Methoxymethamphetamine).

824819 dd. N,N-Dimethylamphetamine.

825820 ee. 3,4,5-Trimethoxyamphetamine.

826821 ff. 4-APB (4-(2-Aminopropyl)benzofuran).

827822 gg. 5-APB (5-(2-Aminopropyl)benzofuran).

828823 hh. 6-APB (6-(2-Aminopropyl)benzofuran).

829824 ii. 7-APB (7-(2-Aminopropyl)benzofuran).

830825 jj. 4-APDB (4-(2-Aminopropyl)-2,3-dihydrobenzofuran).

831826 kk. 5-APDB (5-(2-Aminopropyl)-2,3-dihydrobenzofuran).

832827 ll. 6-APDB (6-(2-Aminopropyl)-2,3-dihydrobenzofuran).

833828 mm. 7-APDB (7-(2-Aminopropyl)-2,3-dihydrobenzofuran).

834829 nn. 4-MAPB (4-(2-Methylaminopropyl)benzofuran).

835830 oo. 5-MAPB (5-(2-Methylaminopropyl)benzofuran).

836831 pp. 6-MAPB (6-(2-Methylaminopropyl)benzofuran).

837832 qq. 7-MAPB (7-(2-Methylaminopropyl)benzofuran).

838833 rr. 5-EAPB (5-(2-Ethylaminopropyl)benzofuran).

839834 ss. 5-MAPDB (5-(2-Methylaminopropyl)-2,3

840835 dihydrobenzofuran),

841

836

842837 which does not include phenethylamine, mescaline as described in

843838 subparagraph 20., substituted cathinones as described in

844839 subparagraph 191., N-Benzyl phenethylamine compounds as

845840 described in subparagraph 193., or methamphetamine as described

846841 in subparagraph (2)(c)5.

847842 193. N-Benzyl Phenethylamine Compounds.—Unless specifically

848843 excepted or unless listed in another schedule, or contained

849844 within a pharmaceutical product approved by the United States

850845 Food and Drug Administration, any material, compound, mixture,

851846 or preparation, including its salts, isomers, esters, or ethers,

852847 and salts of isomers, esters, or ethers, whenever the existence

853848 of such salts is possible within any of the following specific

854849 chemical designations, any compound containing a phenethylamine

855850 structure without a beta-keto group, with substitution on the

856851 nitrogen atom of the amino group with a benzyl substituent, with

857852 or without substitution on the phenyl or benzyl ring to any

858853 extent with alkyl, alkoxy, thio, alkylthio, halide, fused

859854 alkylenedioxy, fused furan, fused benzofuran, or fused

860855 tetrahydropyran substituents, whether or not further substituted

861856 on a ring to any extent, with or without substitution at the

862857 alpha position by any alkyl substituent, including, but not

863858 limited to:

864859 a. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2

865860 methoxybenzyl)]phenethylamine).

866861 b. 25B-NBOH (4-Bromo-2,5-dimethoxy-[N-(2

867862 hydroxybenzyl)]phenethylamine).

868863 c. 25B-NBF (4-Bromo-2,5-dimethoxy-[N-(2

869864 fluorobenzyl)]phenethylamine).

870865 d. 25B-NBMD (4-Bromo-2,5-dimethoxy-[N-(2,3

871866 methylenedioxybenzyl)]phenethylamine).

872867 e. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2

873868 methoxybenzyl)]phenethylamine).

874869 f. 25I-NBOH (4-Iodo-2,5-dimethoxy-[N-(2

875870 hydroxybenzyl)]phenethylamine).

876871 g. 25I-NBF (4-Iodo-2,5-dimethoxy-[N-(2

877872 fluorobenzyl)]phenethylamine).

878873 h. 25I-NBMD (4-Iodo-2,5-dimethoxy-[N-(2,3

879874 methylenedioxybenzyl)]phenethylamine).

880875 i. 25T2-NBOMe (4-Methylthio-2,5-dimethoxy-[N-(2

876 methoxybenzyl)]phenethylamine).

877 j. 25T4-NBOMe (4-Isopropylthio-2,5-dimethoxy-[N-(2

881878 methoxybenzyl)]phenethylamine).

882879 jk. 25T4-NBOMe25T7-NBOMe (4-Isopropylthio-24-(n)-Propylthio-2,5-dimethoxy-[N-(2

883880 methoxybenzyl)]phenethylamine).

884881 kl. 25T7-NBOMe25C-NBOMe (4-(n)-Propylthio-24-Chloro-2,5-dimethoxy-[N-(2

885882 methoxybenzyl)]phenethylamine).

886883 lm. 25C-NBOMe25C-NBOH (4-Chloro-2,5-dimethoxy-[N-(2

884 hydroxybenzyl)]phenethylamine).

885 n. 25C-NBF (4-Chloro-2,5-dimethoxy-[N-(2

886 fluorobenzyl)]phenethylamine).

887 o. 25C-NBMD (4-Chloro-2,5-dimethoxy-[N-(2,3

888 methylenedioxybenzyl)]phenethylamine).

889 p. 25H-NBOMe (2,5-Dimethoxy-[N-(2

887890 methoxybenzyl)]phenethylamine).

891 q. 25H-NBOH (2,5-Dimethoxy-[N-(2

892 hydroxybenzyl)]phenethylamine).

893 r. 25H-NBF (2,5-Dimethoxy-[N-(2

894 fluorobenzyl)]phenethylamine).

888895 ms. 25C-NBOH25D-NBOMe (4-Chloro-24-Methyl-2,5-dimethoxy-[N-(2

889896 hydroxybenzylmethoxybenzyl)]phenethylamine).,

890 n. 25C-NBF (4-Chloro-2,5-dimethoxy-[N-(2

891 fluorobenzyl)]phenethylamine).

892 o. 25C-NBMD (4-Chloro-2,5-dimethoxy-[N-(2,3

893 methylenedioxybenzyl)]phenethylamine).

894 p. 25H-NBOMe (2,5-Dimethoxy-[N-(2

895 methoxybenzyl)]phenethylamine).

896 q. 25H-NBOH (2,5-Dimethoxy-[N-(2

897 hydroxybenzyl)]phenethylamine).

898 r. 25H-NBF (2,5-Dimethoxy-[N-(2

899 fluorobenzyl)]phenethylamine).

900 s. 25D-NBOMe (4-Methyl-2,5-dimethoxy-[N-(2

901 methoxybenzyl)]phenethylamine),

902

897

903898 which does not include substituted cathinones as described in

904899 subparagraph 191.

905900 194. Substituted Tryptamines.—Unless specifically excepted

906901 or unless listed in another schedule, or contained within a

907902 pharmaceutical product approved by the United States Food and

908903 Drug Administration, any material, compound, mixture, or

909904 preparation containing a 2-(1H-indol-3-yl)ethanamine, for

910905 example tryptamine, structure with or without mono- or di

911906 substitution of the amine nitrogen with alkyl or alkenyl groups,

912907 or by inclusion of the amino nitrogen atom in a cyclic

913908 structure, whether or not substituted at the alpha position with

914909 an alkyl group, whether or not substituted on the indole ring to

915910 any extent with any alkyl, alkoxy, halo, hydroxyl, or acetoxy

916911 groups, including, but not limited to:

917912 a. Alpha-Ethyltryptamine.

918913 b. Bufotenine.

919914 c. DET (Diethyltryptamine).

920915 d. DMT (Dimethyltryptamine).

921916 e. MET (N-Methyl-N-ethyltryptamine).

922917 f. DALT (N,N-Diallyltryptamine).

923918 g. EiPT (N-Ethyl-N-isopropyltryptamine).

924919 h. MiPT (N-Methyl-N-isopropyltryptamine).

925920 i. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).

926921 j. 5-Hydroxy-N-methyltryptamine.

927922 k. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).

928923 l. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).

929924 m. Methyltryptamine.

930925 n. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).

931926 o. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).

932927 p. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).

933928 q. DiPT (N,N-Diisopropyltryptamine).

934929 r. DPT (N,N-Dipropyltryptamine).

935930 s. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).

936931 t. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).

937932 u. 4-AcO-DMT (4-Acetoxy-N,N-dimethyltryptamine).

938933 v. 4-AcO-DiPT (4-Acetoxy-N,N-diisopropyltryptamine).

939934 w. 4-Hydroxy-DET (4-Hydroxy-N,N-diethyltryptamine).

940935 x. 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-ethyltryptamine).

941936 y. 4-Hydroxy-MiPT (4-Hydroxy-N-methyl-N

942937 isopropyltryptamine).

943938 z. Methyl-alpha-ethyltryptamine.

944939 aa. Bromo-DALT (Bromo-N,N-diallyltryptamine),

945940

946941 which does not include tryptamine, psilocyn as described in

947942 subparagraph 34., or psilocybin as described in subparagraph 33.

948943 195. Substituted Phenylcyclohexylamines.—Unless

949944 specifically excepted or unless listed in another schedule, or

950945 contained within a pharmaceutical product approved by the United

951946 States Food and Drug Administration, any material, compound,

952947 mixture, or preparation containing a phenylcyclohexylamine

953948 structure, with or without any substitution on the phenyl ring,

954949 any substitution on the cyclohexyl ring, any replacement of the

955950 phenyl ring with a thiophenyl or benzothiophenyl ring, with or

956951 without substitution on the amine with alkyl, dialkyl, or alkoxy

957952 substituents, inclusion of the nitrogen in a cyclic structure,

958953 or any combination of the above, including, but not limited to:

959954 a. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP

960955 (Benocyclidine).

961956 b. PCE (N-Ethyl-1-phenylcyclohexylamine)(Ethylamine analog

962957 of phencyclidine).

963958 c. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine)(Pyrrolidine

959 analog of phencyclidine).

960 d. PCPr (Phenylcyclohexylpropylamine).

961 e. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)(Thiophene

964962 analog of phencyclidine).

963 f. PCEEA (Phenylcyclohexyl(ethoxyethylamine)).

965964 dg. PCPrPCMPA (PhenylcyclohexylpropylaminePhenylcyclohexyl(methoxypropylamine)).

965 h. Methoxetamine.

966 i. 3-Methoxy-PCE ((3-Methoxyphenyl)cyclohexylethylamine).

966967 ej. TCPBromo-PCP (1-[1-(2-ThienylBromophenyl)-cyclohexyl]-piperidinecyclohexylpiperidine)(Thiophene.

968 k. Chloro-PCP ((Chlorophenyl)cyclohexylpiperidine).

969 l. Fluoro-PCP ((Fluorophenyl)cyclohexylpiperidine).

970 m. Hydroxy-PCP ((Hydroxyphenyl)cyclohexylpiperidine).

971 n. Methoxy-PCP ((Methoxyphenyl)cyclohexylpiperidine).

972 o. Methyl-PCP ((Methylphenyl)cyclohexylpiperidine).

973 p. Nitro-PCP ((Nitrophenyl)cyclohexylpiperidine).

967 analog974 q. Oxo-PCP of phencyclidine((Oxophenyl)cyclohexylpiperidine).

968975 fr. PCEEAAmino-PCP (Phenylcyclohexyl(ethoxyethylamineAminophenyl)cyclohexylpiperidine).

976 196. W-15, 4-chloro-N-[1-(2-phenylethyl)-2

977 piperidinylidene]-benzenesulfonamide.

978 197. W-18, 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2

979 piperidinylidene]-benzenesulfonamide.

980 198. AH-7921, 3,4-dichloro-N-[[1

969 g981 (dimethylamino)cyclohexyl]methyl]-benzamide. PCMPA (Phenylcyclohexyl(methoxypropylamine)).

982 199. U47700, trans-3,4-dichloro-N-[2

983 (dimethylamino)cyclohexyl]-N-methyl-benzamide.

984 200. MT-45, 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine,

985 dihydrochloride.

986 Section 2. Paragraph (i) of subsection (1) of section

987 893.13, Florida Statutes, is amended to read:

988 893.13 Prohibited acts; penalties.—

970989 h. Methoxetamine.(1)

971 i. 3-Methoxy-PCE ((3-Methoxyphenyl)cyclohexylethylamine).

972 j. Bromo-PCP ((Bromophenyl)cyclohexylpiperidine).

973 k. Chloro-PCP ((Chlorophenyl)cyclohexylpiperidine).

974 l. Fluoro-PCP ((Fluorophenyl)cyclohexylpiperidine).

975 m. Hydroxy-PCP ((Hydroxyphenyl)cyclohexylpiperidine).

976 n. Methoxy-PCP ((Methoxyphenyl)cyclohexylpiperidine).

977 o. Methyl-PCP ((Methylphenyl)cyclohexylpiperidine).

978 p. Nitro-PCP ((Nitrophenyl)cyclohexylpiperidine).

979 q. Oxo-PCP ((Oxophenyl)cyclohexylpiperidine).

980 r. Amino-PCP ((Aminophenyl)cyclohexylpiperidine).

981 196. W-15, 4-chloro-N-[1-(2-phenylethyl)-2

982 piperidinylidene]-benzenesulfonamide.

983 197. W-18, 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2

984 piperidinylidene]-benzenesulfonamide.

985 198. AH-7921, 3,4-dichloro-N-[[1

986 (dimethylamino)cyclohexyl]methyl]-benzamide.

987 199. U47700, trans-3,4-dichloro-N-[2

988 (dimethylamino)cyclohexyl]-N-methyl-benzamide.

989 200. MT-45, 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine,

990 (i) Except as authorized by this chapter, a person commits

991 a felony of the first degree, punishable as provided in s.

992 775.082, s. 775.083, or s. 775.084, and must be sentenced to a

993 mandatory minimum term of imprisonment of 3 years, if:

994 1. The person sells, manufactures, or delivers, or

995 possesses with intent to sell, manufacture, or deliver, any of

990996 dihydrochloride.the following:

991 (3) SCHEDULE III.—A substance in Schedule III has a

992 potential for abuse less than the substances contained in

993 Schedules I and II and has a currently accepted medical use in

994 treatment in the United States, and abuse of the substance may

995 lead to moderate or low physical dependence or high

996 psychological dependence or, in the case of anabolic steroids,

997 may lead to physical damage. The following substances are

998 controlled in Schedule III:

999 (a) Unless specifically excepted or unless listed in

1000 another schedule, any material, compound, mixture, or

1001 preparation which contains any quantity of the following

1002 substances having a depressant or stimulant effect on the

1003 nervous system:

1004 1. Any substance which contains any quantity of a

1005 derivative of barbituric acid, including thiobarbituric acid, or

1006 any salt of a derivative of barbituric acid or thiobarbituric

1007 acid, including, but not limited to, butabarbital and

1008 butalbital.

997 a. Alfentanil, as described in s. 893.03(2)(b)1.;

998 b. Carfentanil, as described in s. 893.03(2)(b)6.;

999 c. Fentanyl, as described in s. 893.03(2)(b)9.;

1000 d. Sufentanil, as described in s. 893.03(2)(b)30.;

1001 e. A fentanyl derivative, as described in s.

1002 893.03(1)(a)63.;

10091003 2f. Benzphetamine.

1010 3. Buprenorphine.

1011 4. Chlorhexadol.

1012 5. Chlorphentermine.

1013 6. Clortermine.

1014 7. Embutramide.

1015 8. Lysergic acid.

1016 9. Lysergic acid amide.

1017 10. Methyprylon.

1018 11. Perampanel.

1019 12. Phendimetrazine.

1020 13. Sulfondiethylmethane.

1021 14. Sulfonethylmethane.

1022 15. Sulfonmethane.

1023 16. Tiletamine and zolazepam or any salt thereof.

1024

17.

Xylazine

,

except for any drug product approved by the

1025

United States Food and Drug Administration which contains

1026

xylazine or a compounded form of xylazine labeled for veterinary

1027

use

,

which product is

prescribed or dispensed by a veterinarian

1028

licensed under

chapter

474

or labeled and dispensed

by a

1029

veterinarian licensed under chapter 474 or a pharmacy registered

1030

in this state pursuant to a prescription from a veterinarian

1031

licensed under chapter 474 who possesses xylazine for:

1032

a.

A

n animal owned by or under

a

veterinarian

’s care

. As

1033

used in this sub-

subparagraph, the term “

veterinarian

” includes

1034

a government agency or business where animals are located, and

1035

an employee or agent of an agency or business acting within the

1036

scope of their employment or agency.

1037

b.

U

se in government

al

animal-control programs authorized

1038

under applicable

f

ederal

,

s

tate

,

local

, or tribal

law

.

1039

c.

U

se in wildlife programs authorized under applicable

1040

f

ederal

,

s

tate

,

local

, or tribal

law

.

1041 Section 2. Paragraph (i) of subsection (1) of section

1042 893.13, Florida Statutes, is amended to read:

1043 893.13 Prohibited acts; penalties.—

1044 (1)

1045 (i) Except as authorized by this chapter, a person commits

1046 a felony of the first degree, punishable as provided in s.

1047 775.082, s. 775.083, or s. 775.084, and must be sentenced to a

1048 mandatory minimum term of imprisonment of 3 years, if:

1049 1. The person sells, manufactures, or delivers, or

1050 possesses with intent to sell, manufacture, or deliver, any of

1051 the following:

1052 a. Alfentanil, as described in s. 893.03(2)(b)1.;

1053 b. Carfentanil, as described in s. 893.03(2)(b)6.;

1054 c. Fentanyl, as described in s. 893.03(2)(b)9.;

1055 d. Sufentanil, as described in s. 893.03(2)(b)30.;

1056 e. A fentanyl derivative, as described in s.

1057 893.03(1)(a)63.;

1058 f.

Xylazine, as described in s. 893.03(1)(c)37.;

10591004

g.

A controlled substance analog, as described in s.

10601005 893.0356, of any substance described in

sub-subparagraphs a.-

f

.

10611006

sub-subparagraphs a.-e.

; or

10621007

h.

g.

A mixture containing any substance described in

sub

10631008

subparagraphs a.-g.

sub-subparagraphs a.-f.

; and

10641009 2. The substance or mixture listed in subparagraph 1. is in

10651010 a form that resembles, or is mixed, granulated, absorbed, spray

10661011 dried, or aerosolized as or onto, coated on, in whole or in

10671012 part, or solubilized with or into, a product, when such product

10681013 or its packaging further has at least one of the following

10691014 attributes:

10701015 a. Resembles the trade dress of a branded food product,

10711016 consumer food product, or logo food product;

10721017 b. Incorporates an actual or fake registered copyright,

10731018 service mark, or trademark;

10741019 c. Resembles candy, cereal, a gummy, a vitamin, or a

10751020 chewable product, such as a gum or gelatin-based product; or

10761021 d. Contains a cartoon character imprint.

10771022 Section 3. Paragraph (c) of subsection (1) of section

10781023 893.135, Florida Statutes, is amended to read:

10791024 893.135 Trafficking; mandatory sentences; suspension or

10801025 reduction of sentences; conspiracy to engage in trafficking.—

10811026 (1) Except as authorized in this chapter or in chapter 499

10821027 and notwithstanding the provisions of s. 893.13:

10831028 (c)1. A person who knowingly sells, purchases,

10841029 manufactures, delivers, or brings into this state, or who is

10851030 knowingly in actual or constructive possession of, 4 grams or

10861031 more of any morphine, opium, hydromorphone, or any salt,

10871032 derivative, isomer, or salt of an isomer thereof, including

10881033 heroin, as described in s. 893.03(1)(b), (2)(a), (3)(c)3., or

10891034 (3)(c)4., or 4 grams or more of any mixture containing any such

10901035 substance, but less than 30 kilograms of such substance or

10911036 mixture, commits a felony of the first degree, which felony

10921037 shall be known as “trafficking in illegal drugs,” punishable as

10931038 provided in s. 775.082, s. 775.083, or s. 775.084. If the

10941039 quantity involved:

10951040 a. Is 4 grams or more, but less than 14 grams, such person

10961041 shall be sentenced to a mandatory minimum term of imprisonment

10971042 of 3 years and shall be ordered to pay a fine of $50,000.

10981043 b. Is 14 grams or more, but less than 28 grams, such person

10991044 shall be sentenced to a mandatory minimum term of imprisonment

11001045 of 15 years and shall be ordered to pay a fine of $100,000.

11011046 c. Is 28 grams or more, but less than 30 kilograms, such

11021047 person shall be sentenced to a mandatory minimum term of

11031048 imprisonment of 25 years and shall be ordered to pay a fine of

11041049 $500,000.

11051050 2. A person who knowingly sells, purchases, manufactures,

11061051 delivers, or brings into this state, or who is knowingly in

11071052 actual or constructive possession of, 28 grams or more of

11081053 hydrocodone, as described in s. 893.03(2)(a)1.k., codeine, as

11091054 described in s. 893.03(2)(a)1.g., or any salt thereof, or 28

11101055 grams or more of any mixture containing any such substance,

11111056 commits a felony of the first degree, which felony shall be

11121057 known as “trafficking in hydrocodone,” punishable as provided in

11131058 s. 775.082, s. 775.083, or s. 775.084. If the quantity involved:

11141059 a. Is 28 grams or more, but less than 50 grams, such person

11151060 shall be sentenced to a mandatory minimum term of imprisonment

11161061 of 3 years and shall be ordered to pay a fine of $50,000.

11171062 b. Is 50 grams or more, but less than 100 grams, such

11181063 person shall be sentenced to a mandatory minimum term of

11191064 imprisonment of 7 years and shall be ordered to pay a fine of

11201065 $100,000.

11211066 c. Is 100 grams or more, but less than 300 grams, such

1067 person shall be sentenced to a mandatory minimum term of

1068 imprisonment of 15 years and shall be ordered to pay a fine of

1069 $500,000.

1070 d. Is 300 grams or more, but less than 30 kilograms, such

11221071 person shall be sentenced to a mandatory minimum term of

11231072 imprisonment of 1525 years and shall be ordered to pay a fine of

11241073 $500750,000.

1074 3. A person who knowingly sells, purchases, manufactures,

1075 delivers, or brings into this state, or who is knowingly in

1076 actual or constructive possession of, 7 grams or more of

1077 oxycodone, as described in s. 893.03(2)(a)1.q., or any salt

1125 d. Is1078 thereof, 300or 7 grams or more, butof lessany thanmixture 30containing kilograms,any such

1079 substance, commits a felony of the first degree, which felony

1080 shall be known as “trafficking in oxycodone,” punishable as

1081 provided in s. 775.082, s. 775.083, or s. 775.084. If the

1082 quantity involved:

1083 a. Is 7 grams or more, but less than 14 grams, such person

11261084 person shall be sentenced to a mandatory minimum term of imprisonment

1085 of 3 years and shall be ordered to pay a fine of $50,000.

1086 b. Is 14 grams or more, but less than 25 grams, such person

1087 shall be sentenced to a mandatory minimum term of imprisonment

1088 of 7 years and shall be ordered to pay a fine of $100,000.

1089 c. Is 25 grams or more, but less than 100 grams, such

1090 person shall be sentenced to a mandatory minimum term of

11271091 imprisonment of 2515 years and shall be ordered to pay a fine of

11281092 $750500,000.

1093 d. Is 100 grams or more, but less than 30 kilograms, such

1094 person shall be sentenced to a mandatory minimum term of

1095 imprisonment of 25 years and shall be ordered to pay a fine of

1096 $750,000.

11291097 34.a. A person who knowingly sells, purchases, manufactures,

11301098 delivers, or brings into this state, or who is knowingly in

11311099 actual or constructive possession of, 74 grams or more of:

1132 oxycodone1100 (I) Alfentanil, as described in s. 893.03(2)(ab)1.q., or any salt;

1133 thereof, or 7 grams or more of any mixture containing any such

1134 substance, commits a felony of the first degree, which felony

1135 shall be known as “trafficking in oxycodone,” punishable as

1136 provided in s. 775.082, s. 775.083, or s. 775.084. If the

1137 quantity involved:

1138 a. Is 7 grams or more, but less than 14 grams, such person

1139 shall be sentenced to a mandatory minimum term of imprisonment

1140 of 3 years and shall be ordered to pay a fine of $50,000.

1141 b. Is 14 grams or more, but less than 25 grams, such person

1142 shall be sentenced to a mandatory minimum term of imprisonment

1143 of 7 years and shall be ordered to pay a fine of $100,000.

1144 c. Is 25 grams or more, but less than 100 grams, such

1145 person shall be sentenced to a mandatory minimum term of

1146 imprisonment of 15 years and shall be ordered to pay a fine of

1147 $500,000.

1148 d. Is 100 grams or more, but less than 30 kilograms, such

1149 person shall be sentenced to a mandatory minimum term of

1150 imprisonment of 25 years and shall be ordered to pay a fine of

1151 $750,000.

1152 4.a. A person who knowingly sells, purchases, manufactures,

1153 delivers, or brings into this state, or who is knowingly in

1154 actual or constructive possession of, 4 grams or more of:

11551101 (III) AlfentanilCarfentanil, as described in s. 893.03(2)(b)16.;

1102 (III) Fentanyl, as described in s. 893.03(2)(b)9.;

11561103 (IIIV) CarfentanilSufentanil, as described in s. 893.03(2)(b)630.;

11571104 (IIIV) FentanylA fentanyl derivative, as described in s. 893.03(2)(b)9.;

1105 893.03(1)(a)63.;

1106 (VI) A controlled substance analog, as described in s.

1107 893.0356, of any substance described in sub-sub-subparagraphs

1108 (I)-(V); or

11581109 (IVVII) Sufentanil,A asmixture containing any substance described in s. 893.03(2)(b)30.;sub

1159 (V) A fentanyl derivative, as described in s.

1160 893.03(1)(a)63.;

1161 (VI) A controlled substance analog, as described in s.

1110 sub-subparagraphs (I)-(VI),

1111

1112 commits a felony of the first degree, which felony shall be

1113 known as “trafficking in dangerous fentanyl or fentanyl

1114 analogues,” punishable as provided in s. 775.082, s. 775.083, or

1115 s. 775.084.

1162 8931116 b.0356, If ofthe anyquantity substanceinvolved describedunder insub-subparagraph sub-sub-subparagraphsa.:

1163 (I)-(V); or

1164 (VII) A mixture containing any substance described in sub

1165 sub-subparagraphs (I)-(VI),

1166

1167 commits a felony of the first degree, which felony shall be

1168 known as “trafficking in dangerous fentanyl or fentanyl

1169 analogues,” punishable as provided in s. 775.082, s. 775.083, or

1170 s. 775.084.

1171 b. If the quantity involved under sub-subparagraph a.:

11721117 (I) Is 4 grams or more, but less than 14 grams, such person

11731118 shall be sentenced to a mandatory minimum term of imprisonment

11741119 of 7 years

,

and shall be ordered to pay a fine of $50,000.

11751120 (II) Is 14 grams or more, but less than 28 grams, such

11761121 person shall be sentenced to a mandatory minimum term of

11771122 imprisonment of 20 years

,

and shall be ordered to pay a fine of

11781123 $100,000.

11791124 (III) Is 28 grams or more, such person shall be sentenced

11801125 to a mandatory minimum term of imprisonment of 25 years

,

and

11811126 shall be ordered to pay a fine of $500,000.

11821127 c. A person 18 years of age or older who violates sub

11831128 subparagraph a. by knowingly selling or delivering to a minor at

11841129 least 4 grams of a substance or mixture listed in sub

11851130 subparagraph a. shall be sentenced to a mandatory minimum term

11861131 of not less than 25 years and not exceeding life imprisonment,

11871132 and shall be ordered to pay a fine of $1 million if the

11881133 substance or mixture listed in sub-subparagraph a. is in a form

11891134 that resembles, or is mixed, granulated, absorbed, spray-dried,

11901135 or aerosolized as or onto, coated on, in whole or in part, or

11911136 solubilized with or into, a product, when such product or its

11921137 packaging further has at least one of the following attributes:

11931138 (I) Resembles the trade dress of a branded food product,

11941139 consumer food product, or logo food product;

11951140 (II) Incorporates an actual or fake registered copyright,

11961141 service mark, or trademark;

11971142 (III) Resembles candy, cereal, a gummy, a vitamin, or a

11981143 chewable product, such as a gum or gelatin-based product; or

11991144 (IV) Contains a cartoon character imprint.

12001145 5. A person who knowingly sells, purchases, manufactures,

12011146 delivers, or brings into this state, or who is knowingly in

12021147 actual or constructive possession of, 30 kilograms or more of

12031148 any morphine, opium, oxycodone, hydrocodone, codeine,

12041149 hydromorphone, or any salt, derivative, isomer, or salt of an

12051150 isomer thereof, including heroin, as described in s.

12061151 893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or 30 kilograms or

12071152 more of any mixture containing any such substance, commits the

12081153 first degree felony of trafficking in illegal drugs. A person

12091154 who has been convicted of the first degree felony of trafficking

12101155 in illegal drugs under this subparagraph shall be punished by

12111156 life imprisonment and is ineligible for any form of

12121157 discretionary early release except pardon or executive clemency

12131158 or conditional medical release under s. 947.149. However, if the

12141159 court determines that, in addition to committing any act

12151160 specified in this paragraph:

12161161 a. The person intentionally killed an individual or

12171162 counseled, commanded, induced, procured, or caused the

12181163 intentional killing of an individual and such killing was the

12191164 result; or

12201165 b. The person’s conduct in committing that act led to a

12211166 natural, though not inevitable, lethal result,

1222

1167

12231168 such person commits the capital felony of trafficking in illegal

12241169 drugs, punishable as provided in ss. 775.082 and 921.142. A

12251170 person sentenced for a capital felony under this paragraph shall

12261171 also be sentenced to pay the maximum fine provided under

12271172 subparagraph 1.

12281173 6. A person who knowingly brings into this state 60

12291174 kilograms or more of any morphine, opium, oxycodone,

12301175 hydrocodone, codeine, hydromorphone, or any salt, derivative,

12311176 isomer, or salt of an isomer thereof, including heroin, as

12321177 described in s. 893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or

12331178 60 kilograms or more of any mixture containing any such

12341179 substance, and who knows that the probable result of such

12351180 importation would be the death of a person, commits capital

12361181 importation of illegal drugs, a capital felony punishable as

12371182 provided in ss. 775.082 and 921.142. A person sentenced for a

12381183 capital felony under this paragraph shall also be sentenced to

12391184 pay the maximum fine provided under subparagraph 1.

1240

1185

7.

A person who knowingly sells, purchases, manufactures,

12411186

delivers, or brings into this state, or who is knowingly in

1242

1187

actual or constructive possession of, 4 grams or more of

1243

1188

xylazine, as described in s. 893.03(1)(c)37., or any salt

1244

1189

thereof, or 4 grams or more of any mixture containing any such

1245

1190

substance, commits a felony of the first degree, which felony

1246

1191

shall be known as “trafficking in xylazine,” punishable as

12471192

provided in s. 775.082, s. 775.083, or s. 775.084. If the

1248

1193

quantity involved:

12491194

a.

Is 4 grams or more, but less than 14 grams, such person

12501195

shall be sentenced to a mandatory minimum term of imprisonment

12511196

of 7 years and shall be ordered to pay a fine of $50,000.

1252

1197

b.

Is 14 grams or more, but less than 28 grams, such person

1253

1198

shall be sentenced to a mandatory minimum term of imprisonment

1254

1199

of 20 years and shall be ordered to pay a fine of $100,000.

12551200

c.

Is 28 grams or more, such person shall be sentenced to a

12561201

mandatory minimum term of imprisonment of 25 years and shall be

12571202

ordered to pay a fine of $500,000.

12581203 Section 4. This act shall take effect October 1, 2025.

Back to the full text